See more : Spire Inc. (SRCU) Income Statement Analysis – Financial Results
Complete financial analysis of FERMENTA BIOTECH LIMITED (FERMENTA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of FERMENTA BIOTECH LIMITED, a leading company in the Biotechnology industry within the Healthcare sector.
- Praram 9 Hospital Public Company Limited (PR9.BK) Income Statement Analysis – Financial Results
- Sionix Corp. (SINX) Income Statement Analysis – Financial Results
- freenet AG (FRTAY) Income Statement Analysis – Financial Results
- GigCapital4, Inc. (GIGGU) Income Statement Analysis – Financial Results
- Gold Tree Resources Ltd. (GTX.CN) Income Statement Analysis – Financial Results
FERMENTA BIOTECH LIMITED (FERMENTA.BO)
About FERMENTA BIOTECH LIMITED
Fermenta Biotech Ltd. engages in the manufacturing and supply of Vitamin D3. It produces a range of variants such as crystalline, oil, resin in oil, cold water dispersible (CWD) and feed grade powder, which can be used in applications like injectables, soft gel capsules, premixes, as well as food and beverage fortification. The firm operates through the following segments: Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment engages in manufacturing and selling of chemicals, Drugs and enzymes. The property segment engages in renting of properties. The company was founded by Vijay Kumar Raju Datla on May 1, 1951 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.36B | 3.49B | 3.98B | 3.72B | 2.86B | 3.92B | 2.91B | 1.61B | 1.55B | 1.32B | 1.39B | 1.05B |
| Cost of Revenue | 1.53B | 2.88B | 2.99B | 2.58B | 1.78B | 1.99B | 1.70B | 1.31B | 1.21B | 655.05M | 757.21M | 575.07M |
| Gross Profit | 1.82B | 613.39M | 997.87M | 1.14B | 1.08B | 1.93B | 1.22B | 293.06M | 338.61M | 663.92M | 634.30M | 475.62M |
| Gross Profit Ratio | 54.29% | 17.56% | 25.04% | 30.61% | 37.68% | 49.32% | 41.74% | 18.23% | 21.87% | 50.34% | 45.58% | 45.27% |
| Research & Development | 133.41M | 133.86M | 81.87M | 65.39M | 87.91M | 87.91M | 58.47M | 50.77M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 594.35M | 453.85M | 489.45M | 433.64M | 427.47M | 526.33M | 410.19M | 222.58M | 176.66M | 247.12M | 57.76M | 53.56M |
| Selling & Marketing | 26.45M | 29.16M | 24.96M | 19.64M | 85.36M | 27.39M | 26.77M | 12.63M | 16.87M | 12.96M | 34.56M | 24.11M |
| SG&A | 620.80M | 423.75M | 514.41M | 453.28M | 512.84M | 553.72M | 436.97M | 235.21M | 193.53M | 260.08M | 343.65M | 336.82M |
| Other Expenses | 0.00 | -126.70M | -32.94M | -35.70M | -31.23M | -35.38M | 35.74M | -20.79M | -21.24M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 754.21M | 684.31M | 629.22M | 554.37M | 631.98M | 677.01M | 459.70M | 306.77M | 214.77M | 594.24M | 447.43M | 345.49M |
| Cost & Expenses | 2.29B | 3.56B | 3.62B | 3.13B | 2.41B | 2.66B | 2.16B | 1.62B | 1.42B | 1.25B | 1.20B | 920.56M |
| Interest Income | 0.00 | 20.35M | 13.16M | 35.46M | 56.45M | 41.98M | 4.54M | 3.73M | 6.00M | 45.02M | 51.63M | 48.83M |
| Interest Expense | 170.46M | 223.43M | 187.91M | 222.88M | 224.32M | 212.79M | 136.34M | 99.63M | 61.47M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 231.52M | 282.48M | 255.62M | 203.08M | 150.00M | 118.88M | 123.63M | 103.11M | 83.50M | 83.71M | 96.28M | 92.11M |
| EBITDA | 262.68M | -16.85M | 624.26M | 909.43M | 785.09M | 1.62B | 1.02B | 147.46M | 207.33M | 167.43M | 264.29M | 244.30M |
| EBITDA Ratio | 7.83% | 6.06% | 15.67% | 21.15% | 20.80% | 35.09% | 30.20% | 5.56% | 13.39% | 12.69% | 18.99% | 21.68% |
| Operating Income | 1.07B | -70.92M | 368.64M | 583.10M | 443.97M | 1.26B | 756.22M | -13.71M | 123.83M | 83.72M | 168.01M | 135.67M |
| Operating Income Ratio | 31.82% | -2.03% | 9.25% | 15.69% | 15.55% | 32.06% | 25.96% | -0.85% | 8.00% | 6.35% | 12.07% | 12.91% |
| Total Other Income/Expenses | -1.17B | -442.13M | -99.21M | -66.79M | -9.77M | 25.20M | -81.47M | -41.57M | -54.23M | -58.71M | -29.19M | -54.37M |
| Income Before Tax | -98.73M | -513.05M | 269.43M | 516.31M | 434.20M | 1.29B | 759.69M | -55.29M | 69.61M | 24.66M | 135.24M | 81.31M |
| Income Before Tax Ratio | -2.94% | -14.69% | 6.76% | 13.89% | 15.20% | 32.81% | 26.08% | -3.44% | 4.50% | 1.87% | 9.72% | 7.74% |
| Income Tax Expense | 141.36M | 18.27M | 118.83M | 91.00M | -161.00M | 108.04M | 211.32M | 27.01M | 42.48M | 19.29M | 33.91M | 36.72M |
| Net Income | -230.60M | -510.75M | 154.47M | 455.07M | 595.26M | 1.17B | 337.14M | -114.24M | -11.34M | 4.64M | 78.79M | 41.59M |
| Net Income Ratio | -6.87% | -14.62% | 3.88% | 12.24% | 20.84% | 29.94% | 11.57% | -7.11% | -0.73% | 0.35% | 5.66% | 3.96% |
| EPS | -7.99 | -17.70 | 5.35 | 15.78 | 20.63 | 42.68 | 12.25 | -4.15 | -0.41 | 0.17 | 2.86 | 1.51 |
| EPS Diluted | -7.99 | -17.70 | 5.35 | 15.78 | 20.63 | 42.68 | 12.25 | -4.15 | -0.41 | 0.17 | 2.86 | 1.51 |
| Weighted Avg Shares Out | 28.86M | 28.86M | 28.85M | 28.85M | 28.85M | 27.52M | 27.52M | 27.52M | 27.52M | 27.52M | 27.52M | 27.52M |
| Weighted Avg Shares Out (Dil) | 28.87M | 28.86M | 28.85M | 28.85M | 28.85M | 27.52M | 27.52M | 27.52M | 27.52M | 27.52M | 27.52M | 27.52M |
Source: https://incomestatements.info
Category: Stock Reports